Anthrax (Malignant Pustule)

Figure 4.12 A: Cutaneous diphtheria (Courtesy of Public Health Image Library: CDC) B: Cutaneous anthrax (Courtesy of James Steele, CDC) C: Erysipeloid (Reprint from Mandell G, ed. Atlas of Infectious Diseases. Philadelphia PA: Current Medicine LLC; 2002)
Figure 4.12
A: Cutaneous diphtheria
(Courtesy of Public Health
Image Library: CDC
)
B: Cutaneous anthrax
(Courtesy of James Steele,
CDC
)
C: Erysipeloid
(Reprint from Mandell G, ed.
Atlas of Infectious Diseases.
Philadelphia PA: Current
Medicine LLC; 2002
)
(Figure 4.12B)
  • Acute disease in humans and animals caused by Bacillus anthracis, a Gram-positive spore-forming rod
  • Clinical forms: cutaneous, pulmonary, and GI
  • Cutaneous form : “malignant pustule” at inoculation site which spreads and becomes hemorrhagic → central eschar with surrounding nonpitting edema → eschar sloughs leaving shallow ulceration
  • Virulence factors: capsule and two exotoxins: e dema toxin (increases cAMP levels) and lethal toxin (increases TNFα and IL1 β promoting shock/death)
  • Bioterorism-associated treatment: ciprofloxacin or doxycycline (conventional treatment: PCN)